SMARCB1(INI-1)-Deficient Sinonasal Carcinoma: An Evolving Entity.

EZH2 INI-1 SMARCB1 SMARCB1(INI-1)-deficient SNUC SWI/SNF SWItch/Sucrose non-fermentable sinonasal carcinoma sinonasal undifferentiated carcinoma

Journal

Journal of neurological surgery reports
ISSN: 2193-6358
Titre abrégé: J Neurol Surg Rep
Pays: Germany
ID NLM: 101601540

Informations de publication

Date de publication:
Jan 2023
Historique:
received: 15 11 2022
accepted: 23 11 2022
entrez: 30 1 2023
pubmed: 31 1 2023
medline: 31 1 2023
Statut: epublish

Résumé

SMARCB1(INI-1)-deficient sinonasal carcinoma is a rare, poorly differentiated neoplasm with a poor prognosis. Though historically most were identified as sinonasal undifferentiated carcinoma, we now understand it to be a distinct entity. There is currently a general consensus supporting multimodal therapy, though the optimal sequence of surgery, chemotherapy, and radiation has yet to be defined.

Identifiants

pubmed: 36712411
doi: 10.1055/a-1996-1283
pii: JNLS-R-22-Nov-0078
pmc: PMC9883109
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e1-e5

Informations de copyright

The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ).

Déclaration de conflit d'intérêts

Conflict of Interest None declared.

Références

Cancers (Basel). 2022 Jul 05;14(13):
pubmed: 35805058
Cancer Res Treat. 2014 Jul;46(3):209-22
pubmed: 25038756
Nat Rev Cancer. 2011 Jun 09;11(7):481-92
pubmed: 21654818
J Neurol Surg B Skull Base. 2020 Dec;81(6):610-619
pubmed: 33381364
Am J Surg Pathol. 2017 Apr;41(4):458-471
pubmed: 28291122
Annu Rev Pathol. 2015;10:145-71
pubmed: 25387058
World Neurosurg. 2020 Apr;136:305-310
pubmed: 32001406
Semin Diagn Pathol. 2016 Mar;33(2):62-70
pubmed: 26776744
Am J Surg Pathol. 2014 Sep;38(9):1282-9
pubmed: 25007146
Am J Surg Pathol. 2012 Aug;36(8):1216-21
pubmed: 22534723
Adv Anat Pathol. 2020 Mar;27(2):51-60
pubmed: 31876536
Curr Opin Genet Dev. 2016 Feb;36:50-8
pubmed: 27151431
Nat Rev Cancer. 2004 Feb;4(2):133-42
pubmed: 14964309

Auteurs

Sei Y Chung (SY)

Department of Otolaryngology-Head and Neck Surgery, The University of Texas Southwestern Medical Center Ringgold Standard Institution, Dallas, Texas, United States.

Parker Kenee (P)

Department of Otolaryngology-Head and Neck Surgery, The University of Texas Southwestern Medical Center Ringgold Standard Institution, Dallas, Texas, United States.

Tanner Mitton (T)

Department of Otolaryngology-Head and Neck Surgery, The University of Texas Southwestern Medical Center Ringgold Standard Institution, Dallas, Texas, United States.

Ashleigh Halderman (A)

Department of Otolaryngology-Head and Neck Surgery, The University of Texas Southwestern Medical Center Ringgold Standard Institution, Dallas, Texas, United States.

Classifications MeSH